California 2021-2022 Regular Session

California Senate Bill SB1267

Introduced
2/18/22  
Introduced
2/18/22  
Refer
3/2/22  
Refer
3/2/22  
Report Pass
3/21/22  
Refer
3/21/22  
Report Pass
5/19/22  
Report Pass
5/19/22  
Engrossed
5/25/22  
Engrossed
5/25/22  
Refer
6/2/22  
Refer
6/2/22  
Refer
6/6/22  
Refer
6/6/22  
Report Pass
6/14/22  
Report Pass
6/14/22  
Refer
6/14/22  
Refer
6/14/22  
Report Pass
8/11/22  
Report Pass
8/11/22  
Enrolled
8/30/22  
Enrolled
8/30/22  
Chaptered
9/22/22  
Chaptered
9/22/22  
Passed
9/22/22  

Caption

Clinical laboratories.

Impact

The bill will have considerable implications for the field of clinical laboratories in California. By incorporating geneticists and reproductive biologists into the regulatory framework, SB 1267 ensures that these professionals are adequately licensed and that their specialized duties are defined and monitored. This is essential in an era where genetics and reproductive health play increasingly prominent roles in diagnostics and patient care. Furthermore, the establishment of new crimes related to violations of these provisions creates a stricter regulatory environment, promoting higher standards of practice in clinical labs.

Summary

Senate Bill 1267, introduced by Senator Pan, pertains to the regulation of clinical laboratories and the personnel who work within them. This legislation is significant as it amends multiple sections of the Business and Professions Code by adding geneticists and reproductive biologists to the list of clinical laboratory personnel subject to state licensing and oversight. This expansion aims to codify their roles and responsibilities, ensuring that new and existing medical practices evolve with the advancement of science and technology in health care.

Sentiment

The sentiment surrounding SB 1267 appears largely supportive, particularly from stakeholders who recognize the importance of incorporating modern medical practices and specialties into the regulatory framework for clinical laboratories. Proponents view this bill as a progressive step in healthcare regulation, ensuring that California remains at the forefront of medical science. However, there may also be concerns regarding the implications for existing personnel practices within laboratories and how these new regulations might impose additional administrative burdens.

Contention

Notably, the bill indicates that no reimbursement will be required for local agencies or school districts related to the new mandates created by this legislation, which could raise discussions about state versus local responsibilities in regulatory compliance. By shifting certain regulatory powers and responsibilities onto local entities without financial support, some stakeholders may view this as an overreach.

Companion Bills

No companion bills found.

Similar Bills

CA AB2107

Clinical laboratory testing.

CA AB1741

Healing arts: clinical laboratories: personnel.

CA AB1328

Clinical laboratory technology and pharmacists.

CA SB409

Pharmacy practice: testing.